Why the study?
No-reflow is a critical adverse event during saphenous vein graft PCI, and the relationship between the Naples Prognostic Score and no-reflow remained unclear.
Does the Naples Prognostic Score predict no-reflow phenomenon in patients undergoing saphenous vein graft PCI?
Does the Naples Prognostic Score predict no-reflow phenomenon in patients undergoing saphenous vein graft PCI?
The Naples Prognostic Score demonstrates strong discriminative ability (AUC 0.888) for predicting the no-reflow phenomenon during saphenous vein graft PCI.
Answers are grounded in this paper and cite their sources.
NPS may support no-reflow risk stratification in SVG PCI; hypothesis-generating and requires prospective validation.
BACKGROUND: No-reflow is a critical adverse event associated with percutaneous coronary intervention (PCI), particularly during saphenous vein graft (SVG) procedures. The Naples Prognostic Score (NPS) reflects inflammatory status, but its relationship with no-reflow remains unclear. Therefore, we aimed to evaluate the relationship between NPS and no-reflow occurrence following SVG PCI. METHODS: We retrospectively analyzed 286 patients who underwent SVG PCI from January 2020 to January 2024, with a median age of 65 years and 85.7% male. Participants were categorized into low NPS (0-2, 48.6%) and high NPS (3-4, 51.4%) groups. Two nested models were developed by adding NPS (continuous and categorical, respectively) to the base model. RESULTS: : 0.468) and discriminative ability (AUC: 0.888). CONCLUSION: Our findings suggest that NPS is a strong predictor of no-reflow following SVG PCI.
No takes yet. Share an insight, caveat, or question.
Yılmaz et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: